Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
+11.39%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$45.5B
AUM Growth
+$45.5B
(+9.8%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
53.67%
Holding
79
New
3
Increased
22
Reduced
24
Closed
1
Top Buys
| 1 |
Danaher
DHR
|
$859M |
| 2 |
Illumina
ILMN
|
$531M |
| 3 |
Estee Lauder
EL
|
$470M |
| 4 |
Microsoft
MSFT
|
$274M |
| 5 |
Snap
SNAP
|
$253M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$898M |
| 2 |
Ecolab
ECL
|
$692M |
| 3 |
NVIDIA
NVDA
|
$520M |
| 4 |
Nike
NKE
|
$382M |
| 5 |
Adobe
ADBE
|
$218M |
Sector Composition
| 1 | Financials | 20.08% |
| 2 | Communication Services | 19.93% |
| 3 | Technology | 19.59% |
| 4 | Healthcare | 15.67% |
| 5 | Real Estate | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
3M
MMM
$82.2B
| $49.5M | 0.11% |
309,048
-10,500
| -3% | -$1.68M |
|
27
Vertex Pharmaceuticals
VRTX
$103B
| $10.6M | 0.02% |
39,088
| – | – |
|
28
SPDR S&P 500 ETF Trust
SPY
$653B
| $8.49M | 0.02% |
25,345
+8,856
| +54% | +$2.97M |
|
29
Abbott
ABT
$229B
| $8.02M | 0.02% |
73,714
-100
| -0.1% | -$10.9K |
|
30
AbbVie
ABBV
$374B
| $7.05M | 0.02% |
80,480
+900
| +1% | +$78.8K |
|
31
Gilead Sciences
GILD
$140B
| $5.88M | 0.01% |
93,008
-14,274
| -13% | -$902K |
|
|
32
Alphabet (Google) Class C
GOOG
$2.56T
| $5.87M | 0.01% |
3,991
-2,757
| -41% | -$4.05M |
|
33
Utilities Select Sector SPDR Fund
XLU
$20.9B
| $5.02M | 0.01% |
84,571
-27,375
| -24% | -$1.63M |
|
34
Prologis
PLD
$103B
| $4.95M | 0.01% |
49,190
| – | – |
|
35
Bristol-Myers Squibb
BMY
$96.5B
| $4.49M | 0.01% |
74,399
| – | – |
|
36
iShares Select Dividend ETF
DVY
$20.7B
| $4.24M | 0.01% |
52,049
-337
| -0.6% | -$27.5K |
|
37
PepsiCo
PEP
$206B
| $4.19M | 0.01% |
30,259
-900
| -3% | -$125K |
|
38
Digital Realty Trust
DLR
$55.6B
| $4.12M | 0.01% |
28,101
| – | – |
|
39
Royalty Pharma
RPRX
$15.6B
| $3.79M | 0.01% |
90,000
+20,000
| +29% | +$841K |
|
40
Pfizer
PFE
$142B
| $3.18M | 0.01% |
86,728
| – | – |
|
41
Johnson & Johnson
JNJ
$429B
| $2.93M | 0.01% |
19,676
| – | – |
|
42
Sysco
SYY
$38.5B
| $2.49M | 0.01% |
40,074
| – | – |
|
43
JPMorgan Chase
JPM
$824B
| $1.72M | ﹤0.01% |
17,814
+6,400
| +56% | +$616K |
|
44
NextEra Energy, Inc.
NEE
$150B
| $1.55M | ﹤0.01% |
22,400
+16,800
| +300% | +$1.17M |
|
45
Coca-Cola
KO
$297B
| $1.37M | ﹤0.01% |
27,680
| – | – |
|
46
Bank of New York Mellon
BK
$73.8B
| $1.21M | ﹤0.01% |
35,331
-2,976
| -8% | -$102K |
|
47
Cisco
CSCO
$268B
| $1.14M | ﹤0.01% |
28,936
-302
| -1% | -$11.9K |
|
48
Arrowhead Research
ARWR
$3.55B
| $1.08M | ﹤0.01% |
25,000
| – | – |
|
49
Berkshire Hathaway Class B
BRK.B
$1.08T
| $966K | ﹤0.01% |
4,538
| – | – |
|
|
50
Berkshire Hathaway Class A
BRK.A
$1.08T
| $960K | ﹤0.01% |
3
| – | – |
|